Stichting Hemato-Oncologie voor Volwassenen Nederland
Dexrazoxane(Stichting Hemato-Oncologie voor Volwassenen Nederland)은 DLBCL - Diffuse Large B Cell Lymphoma 표적 치료제로, Diffuse Large B-cell Lymphoma (DLBCL); Cardiotoxicity 영역에서 개발·상용화 중입니다. 작용기전: target key signaling pathway. Phase 2에서 효능·안전성 신호를 검증 중입니다. 대표 임상 효능: ORR 2% (ClinicalTrials.gov NCT01606878). 차별점: novel disease-modifying strategy in a condition where current treatments remain largely symptomatic.
DLBCL - Diffuse Large B Cell Lymphoma
Diffuse Large B-cell Lymphoma (DLBCL); Cardiotoxicity
Recruiting
CAR-T cells - also carry cardiotoxic potential, warranting t
novel disease-modifying strategy in a condition where current treatments remain largely symptomatic
target key signaling pathway
topoisomerase II poisoning, redox cycling, mitochondrial dysfunction, and lipid metabolism as drivers of both anticancer efficacy and
biomarkers-including troponins, sphingolipids, cell-free DNA, and immune signatures-show promise for early de
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.
Stichting Hemato-Oncologie voor Volwassenen Nederland
Dexrazoxane(Stichting Hemato-Oncologie voor Volwassenen Nederland)은 DLBCL - Diffuse Large B Cell Lymphoma 표적 치료제로, Diffuse Large B-cell Lymphoma (DLBCL); Cardiotoxicity 영역에서 개발·상용화 중입니다. 작용기전: target key signaling pathway. Phase 2에서 효능·안전성 신호를 검증 중입니다. 대표 임상 효능: ORR 2% (ClinicalTrials.gov NCT01606878). 차별점: novel disease-modifying strategy in a condition where current treatments remain largely symptomatic.
DLBCL - Diffuse Large B Cell Lymphoma
Diffuse Large B-cell Lymphoma (DLBCL); Cardiotoxicity
Recruiting
CAR-T cells - also carry cardiotoxic potential, warranting t
novel disease-modifying strategy in a condition where current treatments remain largely symptomatic
target key signaling pathway
topoisomerase II poisoning, redox cycling, mitochondrial dysfunction, and lipid metabolism as drivers of both anticancer efficacy and
biomarkers-including troponins, sphingolipids, cell-free DNA, and immune signatures-show promise for early de
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.